Healthcare sector, one of the most popular sectors for investors, especially value investors. What are we going to think, health is the one thing we should protect most in our lives, and companies that are involved in this will profit from it perhaps indefinitely. Thanks to them, our society is able to live to a ripe old age. who are your favourites in this sector? For me, I...
Read more
![](https://media.bulios.com/media/ticker/66b59717-b79f-4fae-941b-170a63d9e93a.png?w=100&h=100&mode=crop)
Eli Lilly
LLY
LLY Fair Price
![](https://media.bulios.com/media/ticker/66b59717-b79f-4fae-941b-170a63d9e93a.png?w=100&h=100&mode=crop)
My Notes
Začít psátFeed
![](https://media.bulios.com/media/avatars/b268453b-69ee-46f4-b405-83a8318f9e69.jpeg?w=100&h=100&mode=crop&crop=faces)
US pharmaceutical company Eli Lilly and Company reported its results today, which beat expectations and $LLY+1.8% shares are up more than 15% in response. Fundamentals are quite solid and the stock is up over 40% for the year, which I like and since I see potential in healthcare and I like pharmaceutical and medical companies, I like this company even more :D. The stock may be...
Read more
Zobrazit další komentáře
![](https://bulios.com/public/letters/v1/CB-dark.jpg)
In Patria's coverage, there's one more link "Unexpectedly good quarterly numbers came together today with results from Novo Nordisk's clinical trial for rival Wegova. As Mounjaro is based on a similar principle (GLP-1/GIP analogue), its indication is expected to be extended to cardiovascular disease in the future as well."
How do you see it in the next week? Whose results will you be interested in? For me, the obvious ones are $PLTR+5.3%, $DIS-0.6%, $PARA+3.1%, $LLY+1.8% and $BABA-1.4%.
![](https://media.bulios.com/media/statuses/inside/07bc6075-d50e-4582-9c75-eb4b617a5646.png?w=600&h=300&mode=fill&fill=blur)
In an intermediate clinical trial, the highest dose of Eli Lilly's experimental orforglipron $LLY+1.8% pill led to a 14.7% weight loss in obese or overweight people after 36 weeks, setting a new milestone in the race to develop effective anti-obesity pills.
![LLY](https://media.bulios.com/media/ticker/66b59717-b79f-4fae-941b-170a63d9e93a.png)
Eli Lilly
LLYRead more
Zobrazit další komentáře
![](https://bulios.com/public/letters/v1/WS-dark.jpg)
I think it will be appreciated by far more people than just the Americans... imagine what results you could achieve if you ate right, exercised + supported it with similar pills? What normally takes you a year you could have in a few weeks... :)
Charlie Munger and his view of healthcare in the US.
Charlie, a friend, partner of Warren, has recently been vocal about his concerns about US healthcare, literally stating that it is a system that prolongs death to make more money and comparing patients to African carcasses. 🤔
![](https://media.bulios.com/media/statuses/inside/d2519123-ddcb-49d6-ac68-a47db17e08e4.jpg?w=600&h=300&mode=fill&fill=blur)
Read more
A bit off topic from the classic stocks we cover here, but if we look at the most capitalised US companies, the top ranks are also companies like $UNH-0.4% $LLY+1.8% $PG+0.8% etc. Which according to the chart appear to be endlessly growing companies, which I admit I don't know as much about as the companies we all know like Microsoft, Apple... Do you own any of these companies...
Read more
Zobrazit další komentáře
![](https://media.bulios.com/media/avatars/bd15ab6f-fe26-46d7-9f58-70a54eca0b3c.png?w=100&h=100&mode=crop&crop=faces)
Of the three, I'd probably only be interested in the $PG+0.8%, but it's too expensive.
I have $CVS-0.1% and $PFE+1.3% stocks in my portfolio and plan to look at $LLY+1.8%.